Form 8-K - Current report:
SEC Accession No. 0001213900-25-028646
Filing Date
2025-04-03
Accepted
2025-04-03 16:24:46
Documents
13
Period of Report
2025-03-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ea0237140-8k_oncon.htm   iXBRL 8-K 26299
  Complete submission text file 0001213900-25-028646.txt   202832

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE onco-20250324.xsd EX-101.SCH 3041
3 XBRL LABEL FILE onco-20250324_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE onco-20250324_pre.xml EX-101.PRE 22376
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0237140-8k_oncon_htm.xml XML 3801
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41294 | Film No.: 25809867
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)